PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will speak at the following conferences:
https://mma.prnewswire.com/media/2582388/PTC_LOGO_Logo_Logo.jpg
Cantor Global Healthcare Conference 2025Wednesday, Sept. 3 at 8:35 a.m. ET
Wells Fargo 2025 Healthcare ConferenceThursday, Sept. 4 at 11:00 a.m. ET
Morgan Stanley 23rd Annual Global Healthcare ConferenceMonday, Sept. 8 at 9:15 a.m. ET
The presentations will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentationsand will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes before the start of the webcast to ensure a timely connection.
ABOUTPTC THERAPEUTICS, INC.PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visitwww.ptcbio.comand follow on Facebook, X, and LinkedIn.
For More Information:
Investors:Ellen Cavaleri+1 (615) 618-6228ecavaleri@ptcbio.com
Media:Jeanine Clemente+1 (908) 912-9406jclemente@ptcbio.com
https://c212.net/c/img/favicon.png?sn=NY56078&sd=2025-08-21
View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conferences-302535211.html
SOURCE PTC Therapeutics, Inc.
https://rt.newswire.ca/rt.gif?NewsItemId=NY56078&Transmission_Id=202508210800PR_NEWS_USPR_____NY56078&DateId=20250821